97 related articles for article (PubMed ID: 8664916)
1. [Transitional carcinoma of the bladder at the T1G3 stage: personal experience].
Roggia A; Pozzi E; Malvestiti GM
Arch Ital Urol Androl; 1996 Feb; 68(1):25-8. PubMed ID: 8664916
[TBL] [Abstract][Full Text] [Related]
2. [pT1G3 bladder carcinoma: our experience].
Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
[TBL] [Abstract][Full Text] [Related]
3. [T1G3 bladder tumors: 5 years later].
Pegoraro C; Bondovalli C; Dall'Oglio B; Schiavon L; Luciano M; Parma A
Arch Ital Urol Androl; 1996 Feb; 68(1):35-8. PubMed ID: 8664919
[TBL] [Abstract][Full Text] [Related]
4. Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer.
Bono AV; Lovisolo JA; Saredi G
Eur Urol; 2000 Apr; 37(4):478-83. PubMed ID: 10765080
[TBL] [Abstract][Full Text] [Related]
5. T1G3: What to do?
Mandressi A
Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
[No Abstract] [Full Text] [Related]
6. [T1G3 bladder tumors].
Dormia G; Minervini MS; Malagola G; Bertana F; Luongo P; Mazza L; Gonnella G; Longo G; Castellani R
Arch Ital Urol Androl; 1996 Feb; 68(1):29-32. PubMed ID: 8664917
[TBL] [Abstract][Full Text] [Related]
7. [pT1G3 tumor of the bladder].
Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
[TBL] [Abstract][Full Text] [Related]
8. [Conservative treatment of high-risk (T1G3) transitional carcinoma].
Catanzaro F; Torelli F; Catanzaro M; Cappellano F; Pizzoccaro M; Baruffi M; Sironi D; Pozzoli GL
Arch Ital Urol Androl; 1996 Feb; 68(1):21-4. PubMed ID: 8664915
[TBL] [Abstract][Full Text] [Related]
9. [T1G3 transitional bladder neoplasms: what to do?].
Marcelli G; Bottanelli A; Scattoni V; Baroni GP; Rovellini P; Sciaraffia G; Toia G
Arch Ital Urol Androl; 1996 Feb; 68(1):67-9. PubMed ID: 8664926
[TBL] [Abstract][Full Text] [Related]
10. [Role of BCG in T1G3 bladder transitional cell carcinoma (TCC): our experience].
Comeri GC; Belvisi P; Conti G; Cretarola E; Duvia R; Furgoni R; Gianneo E; Radice GP
Arch Ital Urol Androl; 1996 Feb; 68(1):55-9. PubMed ID: 8664924
[TBL] [Abstract][Full Text] [Related]
11. [pT1G3 bladder carcinoma: parameters of a correct therapy].
Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
[TBL] [Abstract][Full Text] [Related]
12. [T1G3 of the bladder: our experience].
Chisena S; Antonelli D; Bernasconi S; Zaroli A; Buizza C; Belloni M; Mandressi A
Arch Ital Urol Androl; 1996 Feb; 68(1):51-4. PubMed ID: 8664923
[TBL] [Abstract][Full Text] [Related]
13. The optimal management of T1G3 bladder cancer.
Emiliozzi P; Pansadoro A; Pansadoro V
BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
[No Abstract] [Full Text] [Related]
14. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
15. [Radical cystectomy for superficial tumors in the BCG era].
Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
[TBL] [Abstract][Full Text] [Related]
16. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
18. [T1G3 bladder neoplasms: treatment and results].
Cosciani Cunico S; Magri V; Aulenti V; Tosana M; Botturi A
Arch Ital Urol Androl; 1996 Feb; 68(1):47-50. PubMed ID: 8664921
[TBL] [Abstract][Full Text] [Related]
19. Conservative treatment of high grade superficial bladder tumours.
Trinchieri A; Bonacina P; Butti A; Cappoli S; Esposito N; Invernizzi S; Librizzi A; Locatelli G
Arch Ital Urol Androl; 2005 Dec; 77(4):215-8. PubMed ID: 16444936
[TBL] [Abstract][Full Text] [Related]
20. Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG.
Soloway MS
Prog Clin Biol Res; 1990; 350():71-9. PubMed ID: 2117289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
